Yayınlar & Eserler

Makaleler 161
Tümü (161)
SCI-E, SSCI, AHCI (120)
SCI-E, SSCI, AHCI, ESCI (149)
ESCI (28)
Scopus (151)
TRDizin (57)
Diğer Yayınlar (3)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 91

4. The value of scoring systems in terms of phenogroups in the diagnosis of heart failure with preserved ejection fraction

ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

7. WHICH SCORING SYSTEM IS BETTER AT PREDICTING IN-HOSPITAL MORTALITY IN HEART FAILURE EXACERBATION

9th Eurasian Congress of Emergency Medicine & TATKON 100 Anniversary National Congress & 2nd Ultrasonography Symposium in Emergency and Critical Care, Antalya, Türkiye, 9 - 12 Kasım 2023, (Tam Metin Bildiri)

11. CORRELATION BETWEEN IMPEDANCE CARDIOGRAPHY AND FOCUSED LUNG ULTRASONOGRAPHY IN ACUTE HEART FAILURE CLINICAL OUTCOMES IN THE EMERGENCY DEPARTMENT

8th Eurasian Congress of Emergency Medicine & 18th Emergency Medicine Congress of Turkey & 17th World Interactive Network Focused on Critical Ultrasound Congress, Antalya, Türkiye, 1 - 04 Aralık 2022, (Tam Metin Bildiri)

19. A recent survey done in social media: Which areas do you think a heart failure specialist should have competence in?

33. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Türkiye, 5 - 08 Ekim 2017, cilt.18, ss.77, (Özet Bildiri)

21. High sensitive CRP levels is associated with clinical markers of more severe disease in patients with decompensated heart failure.

33. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Türkiye, 5 - 08 Ekim 2017, cilt.18, ss.79, (Özet Bildiri)

22. Comparison of outcome in systolic heart failure patients using ivabradine, digoxin or neither of them: a real life study

Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.58, (Özet Bildiri)

23. Anemia in heart failure is associated with higher CA 125, NT-proBNP and hsCRP levels

Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.448, (Özet Bildiri)

24. Symptoms and signs of heart failure in patients presenting with acute decompensation who were receiving comtemporary guidelines recommended therapy

Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.398, (Özet Bildiri)

25. Chronic kidney disease in heart failure is associated with higher CA 125 and hsCRP levels

Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.567, (Özet Bildiri)

26. Evaluation of Tpe Interval and Tpe/QT Ratio in Patients with Mitral Valve Stenosis Before and After Baloon Valvuloplasty.

13th International Congress of Update in Cardiology and Cardiovascular Surgery (UCCVS), Cesme, Türkiye, 23 - 26 Mart 2017, cilt.119, (Özet Bildiri) identifier

27. POTENTIAL CLINICAL APPLICATION OF LCZ696 IN REAL LIFE CLINICAL PRACTICE BASED ON 2016 ACC/AHA/HFSA AND ESC HEART FAILURE GUIDELINES CRITERIA: RESULTS FROM TREAT HF STUDY

66th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Washington, Kiribati, 17 - 19 Mart 2017, cilt.69, ss.920, (Özet Bildiri) identifier

28. The direct cost components in heart failure with preserved ejection fraction (HF-PEF) in Turkey: The results of a Delphi panel.

ISPOR 19th Annual European Congress, VİYANA, Avusturya, 29 Ekim - 02 Kasım 2016, cilt.19, ss.648-649, (Özet Bildiri)

29. The direct cost components in heart failure with reduced ejection fraction (HF-REF) in Turkey: The results of a Delphi panel.

ISPOR 19th Annual European Congress, Value in Health, VİYANA, Avusturya, 29 Ekim - 02 Kasım 2016, cilt.19, ss.646, (Özet Bildiri)

30. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with recractory hyponatremia

32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Türkiye, 20 - 23 Ekim 2016, cilt.16, ss.1, (Özet Bildiri)

31. Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.

32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Türkiye, 20 - 23 Ekim 2016, cilt.16, ss.2, (Özet Bildiri)

32. Atrial fibrillation is more prevalent in heart failure patients with hyponatremia: Results from TREAT HF study

ESC CONGRESS 2016, EUROPEAN HEART JOURNAL, ROMA, İtalya, 27 - 31 Ağustos 2016, cilt.37, ss.535-536, (Özet Bildiri)

34. Serial changes and associated clinical variables of cardiac troponin release in patients with acute heart failure syndrome

Heart failure 2016, European Journal of Heart Failure, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.100, (Özet Bildiri)

35. Atrial fibrillation is more prevalent in heart failure patients with hyponatremia: results from treat HF

Heart failure 2016,European Heart Journal ( 2016 ), Florence, İtalya, 21 - 24 Mayıs 2016, cilt.37, ss.535-536, (Özet Bildiri)

37. Blood glucose levels increase significantly across higher NYHA functional class categories in patients with chronic heart failure: results from TREAT HF

HEART FAILURE 2016, European Journal of Heart Failure Abstracts Supplement, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.93, (Özet Bildiri)

38. Anemia and low haemoglobin levels are associated with worse functional status in patients with chronic heart failure: results from TREAT HF

Heart failure 2016, European Journal of Heart Failure, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.217, (Özet Bildiri)

39. Potential clinical application of LCZ696 in patients with chronic heart failure in real life clinical practice: results from TREAT HF Study

Heart failure 2016, European Heart Journal, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.37, ss.204-2014, (Özet Bildiri)

42. Anemia and low haemoglobin levels are associated with worse functional status in patients with chronic heart failure: results from TREAT HF

HEART FAILURE 2016, EUROPEAN JOURNAL OF HEART FAILURE, FLORANSA, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.217, (Özet Bildiri)

45. Estimated plasma volume as a determinant of heart failure hospitalization: TREAT HF data.

HEART FAILURE 2016, EUROPEAN JOURNAL OF HEART FAILURE, FLORANSA, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.395, (Özet Bildiri)

46. Acute myocardial infarction in a young woman with a history of systemic lupus erythematosus and kidney transplantation

31. ULUSLARARASI KATILIMLI TÜRK KARDİYOLOJİ KONGRESİ, Antalya, Türkiye, 22 - 25 Ekim 2015, ss.3, (Tam Metin Bildiri)

48. The relation between serum sodium levels and clinical outcomes in Turkish patients hospitalized for heart failure A multi center observational study

31. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, İstanbul, Türkiye, 22 - 25 Ekim 2015, cilt.15, ss.33, (Özet Bildiri)

49. Efficacy and safety of intrvenous high dose versus low dose bolus tirofiban in acute coronary syndrome patients undergoing coronary intervention

31. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, İstanbul, Türkiye, 22 - 25 Ekim 2015, cilt.15, ss.10, (Özet Bildiri)

54. Atrial fibrillation is associated with worse clinical profile in heart failure Data from REALITY HF Study

Heart Failure 2015, European Journal of Heart Failure, Sevilla, İspanya, 23 - 26 Mayıs 2015, cilt.17, ss.353

56. Heart rate reduction with ivabradin in a case with nonischemicheart failure and LBBB who is candidate for CRT

Heart failure 2015,European Journal of Heart Failure Abstracts Supplement, Sevilla, İspanya, 23 - 26 Mayıs 2015, cilt.17, ss.382, (Özet Bildiri)

57. Compared with dobutamine, levosimendan displaysa renoprotective potential in acute heart failure

30th Turkish Cardiology Congresswith International Participation, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

58. Elevated cardiac troponin levels and related clinical variablesin acute decompensated heart failure

30th Turkish Cardiology Congresswith International Participation, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

59. Elevated cardiac troponin levels and related clinical variables in acute decompensated heart failure

30th Turkish Cardiology Congress with International Participation 2014, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

60. Compared with dobutamine levosimendan displays a renoprotective potential in acute heart failure

30th Turkish Cardiology Congress with International Participation 2014, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

62. Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile overdobutamine in patients presenting with acute heart failure syndromes

Heart failure 2014, European Journal of Heart Failure Abstracts Supplement ( 2014 ), atina, Yunanistan, 17 - 20 Mayıs 2014, cilt.16, ss.159, (Özet Bildiri)

64. Does Cardiologist Lead Enhanced Heart Failure Education and Follow-up Program Affect Cardiovascular Mortality Rate?: Hit-Point

Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Texas, Amerika Birleşik Devletleri, 16 - 17 Kasım 2013, cilt.128, (Özet Bildiri) identifier

65. Post-discharge Heart Failure Monitorization Program in Turkey: Hit-PoinT

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri) identifier

66. Ivabradine Treatment Blunts Dobutamine-Induced Increase in Heart Rate in Patients with Acute Decompensated Heart Failure: A Comparative Study with Beta-Blocker Therapy

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri) identifier

67. Effects of Levosimendan and Dobutamine on Systolic Time Intervals in Patients with Acute Decompensated Heart Failure

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri) identifier

68. Ivabradine has no Effect on Cardiac Arrhythmias Observed During Dobutamine Infusion: A Comparative Study with beta Blocker Therapy

29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62, (Özet Bildiri) identifier

71. Subclinical Myocardial Dysfunction in Patients with Pseudoexfoliation Syndrome: A Tissue Doppler Study

3rd World Heart Failure Congress, İstanbul, Türkiye, 29 Kasım - 02 Aralık 2012, cilt.30, ss.55, (Özet Bildiri) identifier

72. Turkish Registry on Hospitalized Acute Heart Failure Patients: TAKTIK

3rd World Heart Failure Congress, İstanbul, Türkiye, 29 Kasım - 02 Aralık 2012, cilt.30, ss.31, (Özet Bildiri) identifier

73. Effects of ivabradine and beta blocker therapy on dobutamine-induced increase in ventricular arrhythmias

3rd World Heart Failure Congress, İstanbul, Türkiye, 29 Kasım - 02 Aralık 2012, cilt.30, ss.4, (Özet Bildiri) identifier

74. Ischemia-modified albumin in patients presenting with acute decompensated heart failure: IMA-HF study

3rd World Heart Failure Congress, İstanbul, Türkiye, 29 Kasım - 02 Aralık 2012, cilt.30, ss.31, (Özet Bildiri) identifier

83. Comparison of Semiparametric, Parametric and Nonparametric ROC Analyses for Continuous Diagnostic Tests Using Simulation Study and Acute Coronary Syndrome Data

Fifth Conference of the Eastern Mediterranean Region of the International Biometric Society, İstanbul, Türkiye, 10 - 14 Mayıs 2009, ss.117, (Özet Bildiri)

85. Fractional flow reserve has the critical role for the decision of reintervention to the angiographically significant in-stent restenosis

18th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, Kiribati, 22 - 27 Ekim 2006, cilt.98, (Özet Bildiri) identifier

89. Evaluation of carbonmonoxide cardiotoxicity with myocardial perfusion SPECT

Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri) identifier

90. Value of radionuclide venticulography in detecting right ventricular ischemia.

Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri) identifier

91. Clinical importance of the initiation pattern of monomorphic ventricular tachycardia

Congress of the European-Society-of-Cardiology, Vienna, Avusturya, 30 Ağustos - 03 Eylül 2003, cilt.24, ss.275, (Özet Bildiri) identifier
Kitaplar 13

1. Kalp Yetersizliğinde Diüretik Kullanımı

DİÜRETİKLER VE KLİNİK KULLANIMLARI, Prof.Dr. Ahmet Uğur YALÇIN (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Nefroloji BD, ESKİŞEHİR), Editör, Türkiye Klinikleri, ss.24-31, 2023

2. Maladaptif Miyokard ve Kalp Yetersizliği

STRES ALTINDA KALP YAPISI: BİRLEŞİK ÇOKLU STRESİN SPESİFİK BULGUSU, yalçın, fatih, Editör, türkiye klinikleri, Ankara, ss.26-31, 2022

3. Sintigrafide çelişkili sonuçlar

Updates in Cardiology, Özpelit Ebru, Editör, AVES, İstanbul, ss.5-7, 2022 Creative Commons License

4. Kardiyojenik şokta klinik ve laboratuvar bulguları

Kardiyojenik Şok, Ahmet Rüçhan Akar, Türkan Kudsioğlu, Asiye Ayça Boyacı, Mehmet Ali Özatik, Editör, Bayçınar Tıbbi Yayıncılık ve Reklam Hiz. Tic. Ltd. Şti, İstanbul, ss.12-18, 2022

5. Kemoterapi İlişkili Kardiyotoksisitenin Belirlenmesinde Kardiyak Biyobelirteçlerin Rolü

Kardiyoonkoloji - Kanser ve Kalp Hastalıkları - 2021, sibel çatırlı enar, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.16-24, 2021 Creative Commons License Sürdürülebilir Kalkınma

6. Kemoterapi İlişkili Kardiyotoksisitenin Belirlenmesinde Kardiyak Biyobelirteçlerin Rolü

Kardiyoonkoloji - Kanser ve Kalp Hastalıkları - 2021, sibel çatırlı enar, Editör, Türkiye Klinikleri Tıp Bilimleri Dergisi, ss.16-24, 2021

7. Amiloid kardiyomiyopati

Kalp Yetersizliğine Yol Açan Nadir Kardiyomiyopatiler: Tanı ve Tedavi Yaklaşımları, ÇAVUŞOĞLU, YÜKSEL, Editör, TÜRKİYE KLİNİKLERİ, Ankara, ss.1-10, 2020

8. Ivabradin, digoksin, hidralazin ve/veya nitrat tedavisi.

Kronik Kalp Yetersizliği Tedavisinde Pratik Yaklaşımlar, YÜKSEL ÇAVUŞOĞLU, Editör, KARE YAYINCILIK, EGE BASIM, İstanbul, ss.28-34, 2016

9. Kalp Yetersizliği ve Hipertansiyon

HİPERTANSİYON TANI VE TEDAVİSİ, ERCAN ERTUĞRUL, Editör, SELEN YAYINCILIK, İstanbul, ss.87-109, 2015

10. Kasılma Kusuru ile Seyreden Kalp Yetersizliği; Tanı ve Tedavi

Kardiyoloji tanı ve tedavi yaklaşımları, ERCAN ERTUĞRUL, Editör, Selen Yayıncılık, İstanbul, ss.243-264, 2015

11. Kalp Yetersizliği ve Hipertansiyon

Hipertansiyon Tanı ve Tedavisi, ERCAN ERTUĞRUL, Editör, Selen Yayıncılık, İstanbul, ss.87-109, 2015

12. Sağ Kalp Yetersizliğinde İnotropik Tedavi

Sağ Kalp Yetersizliği, KELEŞ İBRAHİM, Editör, Akademi Uluslar arası Yayıncılık San. ve Tic. Ltd. Şti, İstanbul, ss.241-251, 2014

13. Kronik Kalp Yetersizliğinde Tedavi

Kalp Yetersizliğine Güncel Bakış, KELEŞ İBRAHİM, Editör, Akademi Uluslar arası Yayıncılık San. ve Tic. Ltd. Şti., ss.71-91, 2012
Metrikler

Yayın

328

Yayın (WoS)

185

Yayın (Scopus)

171

Atıf (WoS)

1313

H-İndeks (WoS)

18

Atıf (Scopus)

1682

H-İndeks (Scopus)

18

Atıf (Scholar)

118

H-İndeks (Scholar)

5

Atıf (TrDizin)

18

H-İndeks (TrDizin)

2

Atıf (Sobiad)

2

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

40

Proje

3

Açık Erişim

39
BM Sürdürülebilir Kalkınma Amaçları